An observational study in Sleep Disorder, Lung Tumor, sponsored by RenJi Hospital. Not yet recruiting. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2023-02-27.
Sponsored by RenJi Hospital · Observational
The goal of this observational study is to observe the lung tumor development in lung tumor patients with long-term sleep disorder. The main questions it aims to answer are:
Researchers will set non-sleep disorder group as control group to see if lung tumor microenvironment change when long-term sleep disorder exists in lung tumor patiens.
7,243 studies on the registry are indexed under Lung Neoplasms; 1,558 are open to participants now.
This study's planned enrollment of 200 is close to the median of 189 across 1,512 observational studies indexed under Lung Neoplasms.
Browse Lung Neoplasms studies →RenJi Hospital is the lead sponsor of 535 studies on the registry; 244 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Participants are 18-75 years old man or women diagnosed with primary lung tumor.
Exclusion Criteria:
patients whose PSQI score\>5
patients whose PSQI score ≦ 5
tumor microenvironment in sleep-disordered lung cancer patients
we use single cell sequencing to analyze microenvironment alterations of tumor tissues in enrolled patients.
Time frame: 3 months after surgery
peripheral blood levels of neurotransmitters in sleep-disordered lung cancer patients
peripheral blood levels of epinephrine, noradrenaline, 5-HT in sleep-disordered lung cancer patients
Time frame: 3 months after surgery
Functional brain imaging in sleep-disordered lung cancer patients
Functional brain imaging
Time frame: 3 months after surgery
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
RenJi Hospital